Transcranial Doppler Monitoring for Brain Injury
Trial Summary
What is the purpose of this trial?
Various methods have been studied to evaluate autoregulation. However, there is currently no universally accepted technique to assess integrity of the cerebral autoregulation neurovascular system. In the last decade, significant progress has been achieved in developing methods to assess cerebral autoregulation by quantifying cross-correlation between spontaneous oscillations in CBF or oxygenation and similar oscillations in arterial blood pressure. In this study the investigators will analyze the relationship between spontaneous fluctuations in mean arterial blood pressure and cerebral blood flow velocity or cerebral regional oxygenation to investigate two novel methods for measuring cerebral autoregulation, Transfer Function Analysis and Wavelet Coherence after acute pediatric brain injury.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Transcranial Doppler for brain injury?
Is Transcranial Doppler Monitoring safe for humans?
How is the treatment Transcranial Doppler unique for brain injury?
Transcranial Doppler (TCD) is unique because it uses ultrasound to measure blood flow in the brain, helping to monitor and predict changes in brain pressure and blood flow after a brain injury. Unlike other treatments, it is non-invasive, meaning it doesn't require surgery or entering the body, and can be used repeatedly to track a patient's condition over time.124510
Research Team
Darryl Miles
Principal Investigator
University of Texas Southwestern Medical Center
Eligibility Criteria
This trial is for children and teens (28 days to 18 years old) who have had a serious brain injury like trauma or stroke within the last day. They must be in the PICU at Children's Medical Center Dallas with an arterial line already placed for care, and some may also have ICP monitoring.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Acute Monitoring
Non-invasive monitoring of cerebral autoregulation using TCD and NIRS over the first 7-10 days post-injury
Follow-up
Participants are monitored for neurologic outcomes using GOSEP and PEDI-CAT at hospital discharge, 3, 6, and 12 months post-injury
Treatment Details
Interventions
- Transcranial Doppler
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor
Southern Methodist University
Collaborator
The University of Texas at Arlington
Collaborator